-
Nnyocha ndị ọkà mmụta sayensị Australia na-egosi na NMN nwere ike ime ka ọkpụkpụ sie ike
Ka anyị na-aka nká, ọkpụkpụ anyị na-aghọ nke na-esighi ike ma na-agbaji, na ọgwụgwọ ugbu a nwere ike ime ka ọkpụkpụ ọkpụkpụ dịkwuo mma.Nsogbu a na-ebilite n'ọtụtụ akụkụ n'ihi na amaghi ihe kpatara osteoporosis (mbelata ọkpụkpụ na njupụta).N'oge na-adịbeghị anya, ndị nchọpụta Australia bipụtara sayensị ...GỤKWUO -
NMN na-ebelata fibrosis intestinal nke radieshon na-ebute site n'ịgbanwe microbiota gut
Fibrosis nke eriri afọ na-akpata radieshon bụ ihe mgbagwoju anya nke ndị na-adịte aka ogologo oge mgbe ọgwụgwọ redio nke afọ na pelvic gasịrị.Ka ọ dị ugbu a, ọ nweghị usoro ụlọ ọgwụ dị maka ọgwụgwọ fibrosis nke eriri afọ na-akpata radieshon.Nnyocha egosiwo na nicotinamide mononucleotide (NMN) nwere ike ...GỤKWUO -
Nyocha Express |Ọmụmụ Mahadum Tsinghua na-egosi na NMN nwere ike ịgwọ mbufụt
Macrophage activation bụ usoro ọrịa na-ebute ọrịa na-adịghị ala ala n'ime ahụ, mana ịgbalite macrophage na-adịgide adịgide nwere ike ibute mbufụt na-adịghị ala ala na ọrịa ndị dị ka nguzogide insulin na ọrịa siri ike dị ka atherosclerosis.PGE 2, nke na-eme ka mmeghachi omume na-egbuke egbuke ...GỤKWUO -
Metabolism Molecular: Mmetụta ọgwụgwọ nke NMN supplementation na polycystic ovary syndrome
N'ime afọ ndị na-adịbeghị anya, na mmụba nke ndụ na-adịghị mma na nrụgide mmekọrịta ọha na eze na-arịwanye elu nke ụmụ nwanyị, ọnụ ọgụgụ nke polycystic ovary syndrome (PCOS) na-apụtawanye ìhè.Ọmụmụ ihe ọmụmụ mba ofesi egosila na ọnọdụ nke polycystic ovary syndrome (PCOS) na ụmụ nwanyị na-amụ nwa ...GỤKWUO -
Ọmụmụ ụlọ ọgwụ na ahụ mmadụ: NMN nwere ike belata ọkwa triglyceride nke ọma
Triglyceride (TG) bụ ụdị abụba nwere nnukwu ọdịnaya n'ime ahụ mmadụ.Akụkụ niile na anụ ahụ nke ahụ mmadụ nwere ike iji triglyceride nye ume, imeju nwere ike ịmepụta triglyceride ma chekwaa ya n'ime imeju.Ọ bụrụ na triglyceride na-abawanye, ọ pụtara na imeju na-agbakọta nke ukwuu f ...GỤKWUO -
FDA kwadoro ibrutinib maka ọgwụgwọ ọrịa graft-versus-host (cGVHD) na-adịghị ala ala na ụmụaka.
N'August 24, 2022, US Food and Drug Administration (FDA) kwadoro ibrutinib maka ọgwụgwọ ụmụaka ndị ọrịa ụmụaka karịrị otu afọ nwere ọrịa graft-versus-host (cGVHD) na-anata Mgbe ọdịda nke 1- ma ọ bụ multi-line. usoro ọgwụgwọ .Ngosipụta a kwadoro bụ nke kachasị maka...GỤKWUO -
Nlebanya akụkọ nke Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside na Nicotinamide Mononucleotide maka Keratinocyte Carcinoma Risk Mbelata
Nicotinamide adenine dinucleotide (NAD+) bụ ebe nyocha nke ndị ọkà mmụta sayensị n'ụlọ na ná mba ọzọ.Ọtụtụ ndị ọkà mmụta sayensị kwenyere na ọkwa NAD + nwere njikọ chiri anya na ọrịa na-adịghị ala ala metụtara afọ, dị ka ọrịa kansa, oke ibu, ọbara mgbali elu na ọrịa shuga.Keratinocyte carcinoma ...GỤKWUO -
Nchọpụta ọhụrụ: NMN nwere ike melite nsogbu ọmụmụ nke oke ibu kpatara
Oocyte bụ mmalite ndụ mmadụ, ọ bụ akwa akwa nke na-emecha ghọọ akwa.Agbanyeghị, ogo oocyte na-ebelata ka ụmụ nwanyị na-eto ma ọ bụ n'ihi ihe ndị dị ka oke ibu, na oocytes dị ala bụ isi ihe kpatara ọmụmụ dị ala na ụmụ nwanyị buru ibu.Otú ọ dị...GỤKWUO -
Nchọpụta sayensị kwuputara |Spermidine nwere ike ịgwọ hypopigmentation
Hypopigmentation bụ ọrịa akpụkpọ, nke na-egosipụtakarị site na mbelata melanin.Mgbaàmà ndị a na-ahụkarị gụnyere vitiligo, albinism na hypopigmentation mgbe mbufụt akpụkpọ.Ka ọ dị ugbu a, ọgwụgwọ bụ isi maka hypopigmentation bụ ọgwụ ọnụ, mana ọgwụ ọnụ ga-ebute akpụkpọ ahụ na ...GỤKWUO -
Ozi ukwu!SyncoZymes (Shanghai) Co., Ltd. Ngwa NMN mbụ nke ụwa gafere asambodo FDA NDI.
Mgbe nyocha siri ike nke kọmitii ọkachamara nke US FDA (US Food and Drug Administration) nwere ikike, na Mee 17, 2022, SyncoZymes (Shanghai) Co., Ltd. natara akwụkwọ ozi nkwenye FDA (AKL): NMN akụrụngwa nke ọma. gafere ND...GỤKWUO -
Ọganihu nyocha na njikọ enzymatic nke nwere ike ibute Clenbuterol na nkwado n'etiti Mahadum Sayensị na Nkà na ụzụ Norwegian na Shangke Biomedical
Clenbuterol, bụ β2-adrenergic agonist (β2-adrenergic agonist), yiri ephedrine (Ephedrine), na-ejikarị ụlọ ọgwụ na-agwọ ọrịa na-adịghị ala ala obstructive pulmonary disease (COPD), A na-ejikwa ya dị ka bronchodilator iji wepụ nnukwu mkparị nke ụkwara ume ọkụ.Na mbido 1...GỤKWUO -
Zhejiang Shangke Biopharmaceutical Co., Ltd. The enzyme catalysis oru ngo gafere ntụle mbido nke isi nyocha na atụmatụ mmepe nke Zhejiang Province.
N'August 2020, "Bio-enzyme Library Development and Green Catalytic Synthesis Application" nke Zhejiang Shangke Biopharmaceutical Co., Ltd. gafere nyocha mbido nke mmemme isi R&D nke Zhejiang nke Ngalaba Sayensị na Teknụzụ nke Zhejiang Provincial ...GỤKWUO
